Dashboard
1
With a growth in Net Sales of 12.96%, the company declared Very Positive results in Jun 25
- The company has declared positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at AED 145.7 MM
- ROCE(HY) Highest at 6.2%
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
2
With ROE of 2.04%, it has a expensive valuation with a 2.00 Price to Book Value
3
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
AED 1,155 Million (Micro Cap)
21.00
NA
0.00%
-0.01
5.92%
1.18
Revenue and Profits:
Net Sales:
300 Million
(Quarterly Results - Jun 2026)
Net Profit:
28 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.78%
0%
-2.78%
6 Months
-7.08%
0%
-7.08%
1 Year
-23.91%
0%
-23.91%
2 Years
8.25%
0%
8.25%
3 Years
22.09%
0%
22.09%
4 Years
-19.85%
0%
-19.85%
5 Years
-43.85%
0%
-43.85%
Gulf Pharmaceutical Industries for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.32%
EBIT Growth (5y)
18.68%
EBIT to Interest (avg)
0.09
Debt to EBITDA (avg)
58.88
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
0.89
Tax Ratio
8.83%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.69%
ROE (avg)
0.76%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
1.23
EV to EBIT
15.93
EV to EBITDA
9.32
EV to Capital Employed
1.23
EV to Sales
1.03
PEG Ratio
0.03
Dividend Yield
NA
ROCE (Latest)
7.74%
ROE (Latest)
5.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
300.30
273.40
9.84%
Operating Profit (PBDIT) excl Other Income
43.60
40.10
8.73%
Interest
3.70
3.20
15.62%
Exceptional Items
0.00
0.00
Consolidate Net Profit
27.80
28.40
-2.11%
Operating Profit Margin (Excl OI)
110.20%
109.00%
0.12%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 9.84% vs -2.15% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is -2.11% vs 294.44% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,075.50
992.20
8.40%
Operating Profit (PBDIT) excl Other Income
109.50
174.00
-37.07%
Interest
30.80
64.20
-52.02%
Exceptional Items
0.00
0.00
Consolidate Net Profit
43.90
-9.30
572.04%
Operating Profit Margin (Excl OI)
47.90%
38.90%
0.90%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 8.40% vs -22.33% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 572.04% vs 87.75% in Dec 2024
About Gulf Pharmaceutical Industries 
Gulf Pharmaceutical Industries
Pharmaceuticals & Biotechnology
Gulf Pharmaceutical Industries PSC (Julphar) is a United Arab Emirates-based public shareholding company engaged in manufacturing and selling of medicines, drugs and other types of pharmaceutical and medical compounds, in addition to cosmetic compounds. The Company maintains a range of product portfolio, which target major therapeutic segments, including endocrinology, anti-infective, cardiovascular and gastroenterology, over-the-counter, nephrology, dermatology, respiratory, metabolic and burn and wound management. The Company operates through a network of more than 10 manufacturing plants, and a logistics network. The Company has approximately 800 products in various dosage forms, and more in the pipeline. The Company’s subsidiaries include Mena Cool FZE, which is engaged in the transportation, and Julphar Pharmaceuticals PLC, which is engaged in Manufacturing of medicines, wrapping and packing materials.
Company Coordinates 
Company Details
Digdaga Airport Road, P.O.Box 997 RAS AL KHAIMAH CITY None : None
Registrar Details






